A new study found that a gene recently recognised as a biomarker for Alzheimer’s disease is actually a cause of it, due to its previously unknown...
Two Alzheimer’s drugs that have been approved in the last two years by the US Food and Drug Administration (FDA) have been shown to extend independent...
A team of researchers has unlocked the details of a cellular pathway that triggers cellular inflammation and ageing and is linked to Alzheimer’s disease, particularly among...
A new study backed by US$5.3m will examine the correlation between walking and mild cognitive impairment (MCI) in the hope of unveiling neural mechanisms underlying the...
Researchers have discovered a surprising link between a chronic gut infection caused by a common virus and the development of Alzheimer’s disease in a subset of...
A successful trial of a drug for memory loss in people with Alzheimer’s disease and schizophrenia brings treatment one step closer. VU319 is the first Vanderbilt...
Anti-CCR5 nanoparticles to treat Alzheimer’s disease are to be developed with support of a major funding boost. Alzheimer’s disease and dementia are debilitating diseases affecting over...
Researchers will explore a system that uses light for non-invasive monitoring of Alzheimer’s Disease. The system will use single-pixel imaging to measure activity in the brain,...
Researchers have shed new light on how mechanical signalling in the brain is disrupted and could lead to the condition which accounts for 60 to 80...
Early detection of cognitive impairment is essential for improving patient outcomes, but primary care settings face significant challenges in screening. A new report summarises key points...
